14 results
10-Q
2022 Q3
PRME
Prime Medicine Inc
14 Nov 22
Quarterly report
4:46pm
patient recruitment, the ability of enrolled patients to complete the clinical trial or the commercial viability of any product candidates that obtain … are able to demonstrate that all future serious adverse events are not product- and/or delivery-related, such occurrences could affect patient recruitment
424B4
PRME
Prime Medicine Inc
21 Oct 22
Prospectus supplement with pricing info
4:47pm
patient recruitment, the ability of enrolled patients to complete the clinical trial or the commercial viability of any product candidates that obtain … are able to demonstrate that all future serious adverse events are not product- and/or delivery-related, such occurrences could affect patient recruitment
S-1/A
134rmzf
13 Oct 22
IPO registration (amended)
10:51am
S-1
ub9df
23 Sep 22
IPO registration
4:12pm
DRS/A
etez v37z
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
sdeh81d2mxh yn36um
6 May 22
Draft registration statement (amended)
12:00am
DRS/A
nsaqguh9ncpfd
8 Apr 22
Draft registration statement (amended)
12:00am
DRS/A
8s3hn
25 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
5rqcnv6nh8
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
yj3 guzso7b11gfi
4 Feb 22
Draft registration statement (amended)
12:00am
DRS
lbze0dc ksgq5swnt676
20 Dec 21
Draft registration statement
12:00am
- Prev
- 1
- Next